Early human augmentation startups used Transcranial Direct Current Stimulation (TDCS) to create wearable devices that could induce specific mental states. One version acted as a stimulant, like "digital caffeine," while another induced relaxation, like "digital cannabis," by delivering low-voltage electricity to specific brain regions.

Contrary to expectations, neuroimaging shows psychedelics reduce total brain activity. However, they simultaneously increase connectivity between disparate brain regions that don't normally communicate. This "rewiring" is correlated with therapeutic outcomes, such as unpairing negative mood states from self-perception networks.

Bryan Johnson explains that as we age, the brain's default mode network (the engine of self and ego) develops stiff, repetitive patterns, narrowing our experience of reality. Psychedelics, especially 5-MeO-DMT, work by powerfully dissolving or 'blasting clean' this network, restoring a more childlike, neuroplastic state.

Psychedelics may treat trauma by reducing activity in the brain's outer cortex (responsible for language, planning). This shifts consciousness to deeper regions like the insular cortex, allowing for profound insights and self-compassion without the usual cognitive filters of guilt and blame.

Psychedelics can be indispensable for revealing that radically different states of consciousness (like unconditional love or egolessness) are achievable. However, the experience is transient. The real work, best addressed by meditation, is integrating these insights and mapping them onto ordinary, everyday waking life.

fMRI studies on meditators at his events reveal they can dial down the brain's "default mode network"—its predictor based on the past—to a degree previously only seen in people on psilocybin, freeing up immense energy for creation.

While research on psychedelics focuses on psychiatric uses like depression and PTSD, Dr. Andrew Weil argues their greatest potential may lie in physical healing. He has witnessed instantaneous reversals of lifelong physical patterns through these experiences.

Current mental health drugs force a choice: slow-acting daily pills or rapid-acting treatments like Spravato that require frequent, life-disrupting clinic visits. Psychedelic therapies offer a new paradigm by combining rapid onset of efficacy with durability lasting weeks or months from a single dose.

Shamanism is a system that uses altered states of consciousness, often induced by psychedelics like Ayahuasca, to gain direct access to other levels of reality. Hancock views this as a technology for inquiry, not simply a spiritual practice or drug use.